Hims & Hers Health Inc has a consensus price target of $28.47 based on the ratings of 20 analysts. The high is $68 issued by Canaccord Genuity on February 19, 2025. The low is $6 issued by Piper Sandler on May 26, 2022. The 3 most-recent analyst ratings were released by B of A Securities, Morgan Stanley, and TD Cowen on April 29, 2025, respectively. With an average price target of $32 between B of A Securities, Morgan Stanley, and TD Cowen, there's an implied -10.36% downside for Hims & Hers Health Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/29/2025 | Buy Now | -27.17% | B of A Securities | Allen Lutz57% | $22 → $26 | Maintains | Underperform | Get Alert |
04/29/2025 | Buy Now | 12.04% | Morgan Stanley | Craig Hettenbach59% | $60 → $40 | Maintains | Equal-Weight | Get Alert |
04/29/2025 | Buy Now | -15.97% | TD Cowen | Jonna Kim54% | $44 → $30 | Downgrade | Buy → Hold | Get Alert |
04/25/2025 | Buy Now | -29.97% | Citigroup | Daniel Grosslight44% | $27 → $25 | Maintains | Sell | Get Alert |
04/10/2025 | Buy Now | -7.56% | Truist Securities | Jailendra Singh37% | $39 → $33 | Maintains | Hold | Get Alert |
03/18/2025 | Buy Now | -38.38% | B of A Securities | Allen Lutz57% | $21 → $22 | Maintains | Underperform | Get Alert |
03/06/2025 | Buy Now | -41.18% | B of A Securities | Allen Lutz57% | $21 → $21 | Reiterates | Underperform → Underperform | Get Alert |
03/06/2025 | Buy Now | -24.37% | Citigroup | Daniel Grosslight44% | $27 → $27 | Reiterates | Sell → Sell | Get Alert |
02/26/2025 | Buy Now | 9.24% | Truist Securities | Jailendra Singh37% | $24 → $39 | Maintains | Hold | Get Alert |
02/25/2025 | Buy Now | 12.04% | Leerink Partners | Michael Cherny78% | $24 → $40 | Maintains | Market Perform | Get Alert |
02/25/2025 | Buy Now | -1.96% | Piper Sandler | Korinne Wolfmeyer47% | $24 → $35 | Maintains | Neutral | Get Alert |
02/25/2025 | Buy Now | 70.87% | Needham | Ryan MacDonald60% | $31 → $61 | Maintains | Buy | Get Alert |
02/25/2025 | Buy Now | -24.37% | Citigroup | Daniel Grosslight44% | $25 → $27 | Maintains | Sell | Get Alert |
02/20/2025 | Buy Now | -41.18% | B of A Securities | Allen Lutz57% | $18 → $21 | Maintains | Underperform | Get Alert |
02/19/2025 | Buy Now | 90.48% | Canaccord Genuity | Maria Ripps72% | $38 → $68 | Maintains | Buy | Get Alert |
02/18/2025 | Buy Now | 68.07% | Morgan Stanley | Craig Hettenbach59% | $42 → $60 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/10/2025 | Buy Now | -29.97% | Citigroup | Daniel Grosslight44% | $24 → $25 | Downgrade | Neutral → Sell | Get Alert |
01/07/2025 | Buy Now | -1.96% | BTIG | David Larsen45% | → $35 | Initiates | → Buy | Get Alert |
01/06/2025 | Buy Now | -32.77% | Piper Sandler | Korinne Wolfmeyer47% | $21 → $24 | Maintains | Neutral | Get Alert |
01/06/2025 | Buy Now | -13.17% | Needham | Ryan MacDonald60% | $28 → $31 | Maintains | Buy | Get Alert |
12/17/2024 | Buy Now | 17.65% | Morgan Stanley | Craig Hettenbach59% | → $42 | Initiates | → Overweight | Get Alert |
12/02/2024 | Buy Now | 6.44% | Canaccord Genuity | Maria Ripps72% | $28 → $38 | Maintains | Buy | Get Alert |
11/20/2024 | Buy Now | -21.57% | TD Cowen | Jonna Kim54% | $28 → $28 | Reiterates | Buy → Buy | Get Alert |
11/14/2024 | Buy Now | -49.58% | B of A Securities | Allen Lutz57% | $32 → $18 | Downgrade | Buy → Underperform | Get Alert |
11/08/2024 | Buy Now | -21.57% | TD Cowen | Jonna Kim54% | $25 → $28 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | -24.37% | Deutsche Bank | George Hill62% | $23 → $27 | Maintains | Hold | Get Alert |
11/05/2024 | Buy Now | -41.18% | Piper Sandler | Korinne Wolfmeyer47% | $18 → $21 | Reiterates | Neutral → Neutral | Get Alert |
11/05/2024 | Buy Now | -21.57% | Canaccord Genuity | Maria Ripps72% | $24 → $28 | Maintains | Buy | Get Alert |
10/21/2024 | Buy Now | -29.97% | B of A Securities | Michael Cherny78% | $23 → $25 | Maintains | Buy | Get Alert |
10/14/2024 | Buy Now | -35.57% | B of A Securities | Michael Cherny78% | $20 → $23 | Maintains | Buy | Get Alert |
09/13/2024 | Buy Now | -43.98% | B of A Securities | Michael Cherny78% | $24 → $20 | Maintains | Buy | Get Alert |
08/22/2024 | Buy Now | -32.77% | Needham | Ryan MacDonald60% | → $24 | Initiates | → Buy | Get Alert |
08/07/2024 | Buy Now | -35.57% | Deutsche Bank | George Hill62% | $16 → $23 | Maintains | Hold | Get Alert |
08/06/2024 | Buy Now | -49.58% | Piper Sandler | Korinne Wolfmeyer47% | $18 → $18 | Reiterates | Neutral → Neutral | Get Alert |
07/18/2024 | Buy Now | -35.57% | Truist Securities | Jailendra Singh37% | $13 → $23 | Maintains | Hold | Get Alert |
07/11/2024 | Buy Now | -29.97% | TD Cowen | Jonna Kim54% | $15 → $25 | Maintains | Buy | Get Alert |
07/11/2024 | Buy Now | -49.58% | Piper Sandler | Korinne Wolfmeyer47% | $16 → $18 | Maintains | Neutral | Get Alert |
06/27/2024 | Buy Now | -35.57% | Jefferies | Glen Santangelo50% | $14 → $23 | Maintains | Hold | Get Alert |
06/13/2024 | Buy Now | -27.17% | B of A Securities | Michael Cherny78% | $22 → $26 | Maintains | Buy | Get Alert |
06/03/2024 | Buy Now | -38.38% | B of A Securities | Michael Cherny78% | $17.25 → $22 | Maintains | Buy | Get Alert |
05/22/2024 | Buy Now | -32.77% | Canaccord Genuity | Maria Ripps72% | $20 → $24 | Maintains | Buy | Get Alert |
05/22/2024 | Buy Now | -43.98% | Citigroup | Daniel Grosslight44% | $16 → $20 | Downgrade | Buy → Neutral | Get Alert |
05/07/2024 | Buy Now | -55.18% | Deutsche Bank | George Hill62% | $14 → $16 | Maintains | Hold | Get Alert |
05/07/2024 | Buy Now | -63.59% | Piper Sandler | Korinne Wolfmeyer47% | $11 → $13 | Maintains | Neutral | Get Alert |
04/16/2024 | Buy Now | -57.98% | Jefferies | Glen Santangelo50% | $17 → $15 | Downgrade | Buy → Hold | Get Alert |
04/10/2024 | Buy Now | -43.98% | Canaccord Genuity | Maria Ripps72% | → $20 | Initiates | → Buy | Get Alert |
02/27/2024 | Buy Now | -52.38% | Guggenheim | Jack Wallace57% | $15 → $17 | Maintains | Buy | Get Alert |
02/27/2024 | Buy Now | -55.18% | Citigroup | Daniel Grosslight44% | $12 → $16 | Maintains | Buy | Get Alert |
02/27/2024 | Buy Now | -69.19% | Piper Sandler | Michael Lavery66% | $9 → $11 | Maintains | Neutral | Get Alert |
02/27/2024 | Buy Now | -63.59% | Truist Securities | Jailendra Singh37% | $10 → $13 | Maintains | Hold | Get Alert |
02/26/2024 | Buy Now | -71.99% | Leerink Partners | Michael Cherny78% | → $10 | Initiates | → Market Perform | Get Alert |
01/05/2024 | Buy Now | -57.98% | Tigress Financial | Ivan Feinseth72% | $14 → $15 | Maintains | Buy | Get Alert |
08/09/2023 | Buy Now | -71.99% | Truist Securities | Jailendra Singh37% | $12 → $10 | Maintains | Hold | Get Alert |
08/08/2023 | Buy Now | -60.78% | Credit Suisse | Jonathan Yong66% | → $14 | Reiterates | Outperform → Outperform | Get Alert |
07/28/2023 | Buy Now | -69.19% | TD Cowen | Jonna Kim54% | → $11 | Initiates | → Outperform | Get Alert |
06/15/2023 | Buy Now | -60.78% | Tigress Financial | Ivan Feinseth72% | $12 → $14 | Reiterates | → Buy | Get Alert |
05/30/2023 | Buy Now | -69.19% | Piper Sandler | Michael Lavery66% | $12 → $11 | Maintains | Neutral | Get Alert |
05/09/2023 | Buy Now | -57.98% | B of A Securities | Michael Cherny78% | $13.5 → $15 | Maintains | Buy | Get Alert |
05/09/2023 | Buy Now | -66.39% | Piper Sandler | Michael Lavery66% | $11 → $12 | Maintains | Neutral | Get Alert |
04/27/2023 | Buy Now | -49.58% | Guggenheim | Jack Wallace57% | $15 → $18 | Maintains | Buy | Get Alert |
04/26/2023 | Buy Now | -69.19% | Piper Sandler | Korinne Wolfmeyer47% | $10 → $11 | Maintains | Neutral | Get Alert |
04/11/2023 | Buy Now | -71.99% | Baird | Vikram Kesavabhotla51% | → $10 | Initiates | → Neutral | Get Alert |
03/01/2023 | Buy Now | -60.78% | Credit Suisse | Jonathan Yong66% | $8 → $14 | Maintains | Outperform | Get Alert |
02/28/2023 | Buy Now | -57.98% | Guggenheim | Jack Wallace57% | → $15 | Reiterates | → Buy | Get Alert |
02/28/2023 | Buy Now | -66.39% | Truist Securities | Jailendra Singh37% | $7 → $12 | Maintains | Hold | Get Alert |
02/28/2023 | Buy Now | -60.78% | Citigroup | Daniel Grosslight44% | $9 → $14 | Maintains | Buy | Get Alert |
02/28/2023 | Buy Now | -71.99% | Piper Sandler | Korinne Wolfmeyer47% | $7 → $10 | Maintains | Neutral | Get Alert |
02/28/2023 | Buy Now | -62.18% | B of A Securities | Michael Cherny78% | $11.5 → $13.5 | Maintains | Buy | Get Alert |
02/09/2023 | Buy Now | -69.19% | Jefferies | Glen Santangelo50% | $7 → $11 | Upgrade | Hold → Buy | Get Alert |
01/12/2023 | Buy Now | -66.39% | Tigress Financial | Ivan Feinseth72% | $11 → $12 | Maintains | Buy | Get Alert |
11/08/2022 | Buy Now | -76.19% | B of A Securities | Michael Cherny78% | $7.5 → $8.5 | Upgrade | Neutral → Buy | Get Alert |
11/08/2022 | Buy Now | — | SVB Leerink | Joy Zhang26% | — | Upgrade | Underperform → Market Perform | Get Alert |
10/17/2022 | Buy Now | -83.19% | Piper Sandler | Korinne Wolfmeyer47% | $8 → $6 | Downgrade | Overweight → Neutral | Get Alert |
09/07/2022 | Buy Now | -80.39% | Truist Securities | Jailendra Singh37% | → $7 | Initiates | → Hold | Get Alert |
08/10/2022 | Buy Now | -77.59% | Credit Suisse | Jonathan Yong66% | $7 → $8 | Maintains | Outperform | Get Alert |
08/09/2022 | Buy Now | -85.99% | SVB Leerink | Joy Zhang26% | $4 → $5 | Maintains | Underperform | Get Alert |
07/15/2022 | Buy Now | -88.8% | SVB Leerink | Joy Zhang26% | → $4 | Initiates | → Underperform | Get Alert |
05/26/2022 | Buy Now | -83.19% | Piper Sandler | Sean Wieland46% | $8 → $6 | Maintains | Overweight | Get Alert |
05/10/2022 | Buy Now | -83.19% | Citigroup | Daniel Grosslight44% | $9 → $6 | Maintains | Buy | Get Alert |
The latest price target for Hims & Hers Health (NYSE:HIMS) was reported by B of A Securities on April 29, 2025. The analyst firm set a price target for $26.00 expecting HIMS to fall to within 12 months (a possible -27.17% downside). 44 analyst firms have reported ratings in the last year.
The latest analyst rating for Hims & Hers Health (NYSE:HIMS) was provided by B of A Securities, and Hims & Hers Health maintained their underperform rating.
The last upgrade for Hims & Hers Health Inc happened on February 9, 2023 when Jefferies raised their price target to $11. Jefferies previously had a hold for Hims & Hers Health Inc.
The last downgrade for Hims & Hers Health Inc happened on April 29, 2025 when TD Cowen changed their price target from $44 to $30 for Hims & Hers Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Hims & Hers Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Hims & Hers Health was filed on April 29, 2025 so you should expect the next rating to be made available sometime around April 29, 2026.
While ratings are subjective and will change, the latest Hims & Hers Health (HIMS) rating was a maintained with a price target of $22.00 to $26.00. The current price Hims & Hers Health (HIMS) is trading at is $35.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.